Osteogenic potential evaluation of biotin combined with magnesium-doped hydroxyapatite sustained-release film
Source abstract
Abstract
Biotin is one of the water-soluble B-complex group of vitamins. Recent studies have found that the relative protein expression of BMP2, BSP and OPG in MC3T3-E1 cells is prominent after 14 days of co-culture with biotin film, especially for BMP2. It is also found that the rapid degradation of biotin film in vivo limits its application value. In this work, magnesium-doped hydroxyapatite (MgHA) film can form a porous network structure as a biological sustained-release film. Therefore, the multilayer (MgHA|biotin|MgHA|biotin) film was prepared by pulsed laser assisted electron beam deposition technique. The morphology, structure and properties of biotin film and multilayer film were analyzed and characterized. Also, the osteogenic effect of biotin film and multilayer film was evaluated after implantation into the femoral bone marrow cavity of SD rats. The results of micro-CT scan and 3D reconstruction showed that there were a large number of trabecular bones around the multilayer film, which was superior to biotin film in osteogenesis. Hematoxylin-eosin staining showed cancellous bone structure and intact bone marrow structure around the multilayer film, and the newly formed bone became lamellar. Masson-trichromatic staining revealed abundant osteoid and braided bone formation around the multilayer film. In conclusion, MgHA sustained release film can realize the continuous release of bioactive drugs, which provides a new route to accelerate the repair of bone defects.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Polymer Surface Interaction Studies · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Polyak · 2015 · 04
2. Effects of biotin on promoting anammox bacterial activity
3. Effects of different levels of dietary biotin on the performance and bone structure of broilers10.4081/ijas.2007.5 ↗
4. Bone tissue engineering by using calcium phosphate glass scaffolds and the avidin-biotin binding system10.1007/s10439-015-1347-y ↗
5. Self-assembled human adipose-derived stem cell-derived extracellular vesicle-functionalized biotin-doped polypyrrole titanium with long-term stability and potential osteoinductive ability10.1021/acsami.9b17015 ↗
6. Effect of an avidin–biotin binding system on chondrocyte adhesion, growth and gene expression10.1016/j.biomaterials.2004.08.014 ↗
7. Effects of an avidin-biotin binding system on chondrocyte adhesion and growth on biodegradable polymers10.1002/mabi.200400144 ↗
8. Dexamethasone conjugation to biodegradable avidin-nucleic-acid-nano-assemblies promotes selective liver targeting and improves therapeutic efficacy in an autoimmune hepatitis murine model10.1021/acsnano.8b09655 ↗
9. Artificial metalloenzymes based on the biotin−avidin technology: enantioselective catalysis and beyond10.1021/ar100099u ↗
10. Radiation synthesis of magnesium doped nano hydroxyapatite/(acacia-gelatin) scaffold for bone tissue regeneration: in vitro drug release study10.1007/s10904-019-01418-3 ↗
11. Effects of magnesium deficiency on mechanisms of insulin resistance in Type 2 diabetes: focusing on the processes of insulin secretion and signaling10.3390/ijms20061351 ↗
12. Effect of magnesium-degradation products and hypoxia on the angiogenesis of human umbilical vein endothelial cells10.1016/j.actbio.2019.02.018 ↗
13. Osteoimmunomodulatory properties of magnesium scaffolds coated with β-tricalcium phosphate10.1016/j.biomaterials.2014.06.038 ↗
14. Porous magnesium-based scaffolds for tissue engineering10.1016/j.msec.2016.11.027 ↗
15. Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect10.1016/j.biomaterials.2019.01.013 ↗
16. Biodegradable magnesium-incorporated poly(l -lactic acid) microspheres for manipulation of drug release and alleviation of inflammatory response10.1021/acsami.9b03766 ↗
17. Magnesium and fluoride doped hydroxyapatite coatings grown by pulsed laser deposition for promoting titanium implant cytocompatibility10.1016/j.apsusc.2020.146069 ↗
18. Studies of magnesium - hydroxyapatite micro/nano film for drug sustained release10.1016/j.apsusc.2021.150598 ↗
19. Controlled nucleation of hydroxyapatite on alginate scaffolds for stem cell-based bone tissue engineering10.1002/jbm.a.32833 ↗
20. Stem cell recruitment based on scaffold features for bone tissue engineering10.1039/D0BM01591A ↗
21. Features of electron beam deposition of polymer coatings with the prolonged release of the drug component10.1016/j.msec.2020.110730 ↗
22. Synthesis and biological evaluation of biotin-conjugated Portulaca oleracea polysaccharides10.1039/D1RA02226A ↗
23. Roughness threshold for cell attachment and proliferation on plasma micro-nanotextured polymeric surfaces: the case of primary human skin fibroblasts and mouse immortalized 3T3 fibroblasts10.1088/0022-3727/49/30/304002 ↗
24. Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblast differentiation10.1263/jbb.102.425 ↗
25. Bone morphogenetic protein-2 in development and bone homeostasis10.3390/jdb8030019 ↗
26. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway10.1074/jbc.M011265200 ↗
27. The role of the SIBLING, bone sialoprotein in skeletal biology — contribution of mouse experimental genetics10.1016/j.matbio.2015.12.011 ↗
28. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro10.1016/j.bone.2007.04.191 ↗
29. Transcriptional regulation of bone sialoprotein gene expression by Osx10.1016/j.bbrc.2016.05.164 ↗
30. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro10.1002/jcb.27468 ↗
31. Biology of RANK, RANKL, and osteoprotegerin10.1186/ar2165 ↗
32. Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts10.2319/050210-238.1 ↗
33. Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen scaffolds10.1126/sciadv.aaw4991 ↗
34. Early Cambrian ocean mixing recorded by phosphorite successions in the Nanhua Basin, South China10.1016/j.precamres.2019.105414 ↗
35. Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells10.1074/jbc.C000290200 ↗
36. Bioinspired surfaces with wettability: biomolecule adhesion behaviors10.1039/C9BM01729A ↗
37. Surface free energy predominates in cell adhesion to hydroxyapatite through wettability10.1016/j.msec.2016.01.037 ↗
38. Micro-Computed tomography assessment of human alveolar bone: bone density and three-dimensional micro-architecture10.1111/cid.12109 ↗
39. SLPI is a critical mediator that controls PTH-induced bone formation10.1038/s41467-021-22402-x ↗
40. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH10.1016/j.bone.2006.07.013 ↗
41. Micro-CT analysis of new bone formation around implant with electrochemically deposited apatite10.4028/www.scientific.net/KEM.240-242.611 ↗
42. The histological study of osseous regeneration following implantation of various bone graft biomaterials10.4103/1119-3077.183302 ↗
43. A histological and biomechanical study of bone stress and bone remodeling around immediately loaded implants10.1007/s11427-014-4657-7 ↗
44. Histological observation of regions around bone tunnels after compression of the bone tunnel wall in ligament reconstruction10.1267/ahc.10036 ↗
45. Newly formed bone induced by recombinant human bone morphogenetic protein-210.1097/ID.0000000000000564 ↗